Literature DB >> 2900144

Ethnic differences in response to beta-blockade: fact or artefact? A study with bisoprolol and propranolol.

P H Joubert1, C P Venter, A Wellstein.   

Abstract

A randomized, double-blind, placebo-controlled study was performed in 8 white and 8 black volunteers matched for sex, age and mass. The effect of 3 intravenous doses of a new, cardioselective beta-adrenergic blocker, bisoprolol, on the heart rate increase after standardized exercise was compared to that of 3 doses of propranolol. As described previously for propranolol, black volunteers showed less response than whites to beta-blockade assessed in terms of the reduction in exercise-induced tachycardia. The effects of the two beta-blockers were similar and the apparent ethnic difference was seen with both drugs. It has previously been shown that black volunteers have a higher intrinsic heart rate (i.e. heart rate after parasympathetic and beta-adrenergic blockade of the heart) than whites, but their resting heart rates are similar because of greater parasympathetic tone in blacks. When exercise-load was calculated as increase in heart rate above that after atropinization, no ethnic differences were seen. It is suggested that in populations that are heterogenous in terms of the heart rate increase after atropine, work load should be standardized in terms of the increase in heart rate over the atropine heart rate rather than on absolute heart rate. The apparent ethnic difference represents a flaw in methodology as applied to a heterogenous volunteer population.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2900144     DOI: 10.1007/bf00542437

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  14 in total

1.  Comparative pharmacokinetics of intravenous propranolol in black and white volunteers.

Authors:  C P Venter; P H Joubert; W J Strydom
Journal:  J Cardiovasc Pharmacol       Date:  1985 Mar-Apr       Impact factor: 3.105

2.  Ineffectiveness of propranolol in hypertensive Jamaicans.

Authors:  G S Humphreys; D G Delvin
Journal:  Br Med J       Date:  1968-06-08

3.  Penbutolol: beta-adrenoceptor interaction and the time course of plasma concentrations explain its prolonged duration of action in man.

Authors:  A Wellstein; D Palm
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

4.  Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man.

Authors:  A Wellstein; D Palm; H F Pitschner; G G Belz
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

5.  Racial differences in blood pressure control.

Authors:  A W Voors; G S Berenson; E R Dalferes; L S Webber; S E Shuler
Journal:  Science       Date:  1979-06-08       Impact factor: 47.728

6.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

7.  Trial of atenolol and chlorthalidone for hypertension in black South Africans.

Authors:  Y K Seedat
Journal:  Br Med J       Date:  1980-11-08

8.  Once-daily atenolol in hypertensive Zimbabwean blacks. A double-blind trial using two different doses.

Authors:  C P Abson; L M Levy; G Eyherabide
Journal:  S Afr Med J       Date:  1981-07-11

9.  Ethnic differences in beta-1-adrenoceptor sensitivity.

Authors:  C P Venter; P H Joubert
Journal:  S Afr Med J       Date:  1982-11-27

10.  Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.

Authors:  G Leopold; W Ungethüm; J Pabst; Z Simane; K U Bühring; H Wiemann
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

View more
  3 in total

Review 1.  Ethnic differences in drug disposition and responsiveness.

Authors:  A J Wood; H H Zhou
Journal:  Clin Pharmacokinet       Date:  1991-05       Impact factor: 6.447

Review 2.  Clinical trials and transethnic pharmacology.

Authors:  M E Kitler
Journal:  Drug Saf       Date:  1994-11       Impact factor: 5.606

3.  Beta-1-adrenoceptor genetic variants and ethnicity independently affect response to beta-blockade.

Authors:  Daniel Kurnik; Chun Li; Gbenga G Sofowora; Eitan A Friedman; Mordechai Muszkat; Hong-Guang Xie; Paul A Harris; Scott M Williams; Usha B Nair; Alastair J J Wood; C Michael Stein
Journal:  Pharmacogenet Genomics       Date:  2008-10       Impact factor: 2.089

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.